
16
OMNISWD
®
USER MANUAL
COPYRIGHT © 2017, ACCELERATED CARE PLUS CORP., ALL RIGHTS RESERVED
appropriate (assuming the patient has normal sensation). Preprogrammed doses may be selected on the front panel
for ease of operator selection.
IV.
Safety
Due to the design of the drum inductive applicator, a strong magnetic field is produced with only a small incidental
amount of electrical field. As the distance away from the drum inductive applicator increases, the amount of energy
in the magnetic field drops rapidly and becomes equal to the energy in the electrical field. The nominal distance
where this occurs is called the boundary between near and far fields. This distance has been measured to be
approximately 5 feet. However, both the magnetic and electrical field intensities are well below all applicable RF
exposure standards at a distance of 2 feet from the drum inductive applicator.
V.
Dosage
Proper dosage is most important for effective application of therapy. Dosage levels on the OmniSWD
®
are
established based on the pulse duration and pulse rate, i.e.: the greater the rate and duration, the more energy
produced and the greater the thermal effect. The output peak power is fixed at 200 watts. Schliephake and Lehman
developed the following dosage pattern:
Dose - Variable (VAR):
Barely detectable warmth set for low pulse duration [65
sec] and rate [100-400pps],
acute inflammatory conditions, and pain.
Dose 1 -
1
T:
Mild warmth (pulse duration [100
sec] and rate [800pps] sub-acute
inflammatory process).
Dose 2 - 2
T:
Moderate warmth (pain syndromes, muscle spasm and chronic inflammation, increased
blood flow pulse duration [200
sec] and rate [800pps]), stretch collagen tissue in
patients with reduced muscle mass, stretch collagenous tissue in patients with reduced
muscle mass and circulation.
Dose 4 - 4
T:
Vigorous heating (stretch collagenous tissue pulse duration [400
sec] and rate [800pps]).
Treatment Time
Generally treatment beyond 30 minutes is not recommended. General rule: Acute and inflammatory process 15-30
minutes, 1
T, 2
T, 4
T: 15 minutes treatment time. Always start with a low dose, and increase to a higher dose if
needed, following patient response to treatment. Always start with a low dose and move to a higher dose if needed
following the patient response and sensation (use sub-thermal treatment for patients with reduced or absent sensation).